5-Methoxy-N,N-DIMETHYLTRYPTAMINE (5-MeO-DMT) Formulations
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,980,605 | 5-Methoxy-N,N-DIMETHYLTRYPTAMINE (5-MeO-DMT) Formulations In force · High confidence | Beckley Psytech Limited | In force | High confidence | ||
| US 12,246,005 | 5-Methoxy-N,N-DIMETHYLTRYPTAMINE (5-MeO-DMT) Formulations In force · High confidence | Beckley Psytech Limited | In force | High confidence | ||
| Application 19/040,537 | 5-Methoxy-N,N-DIMETHYLTRYPTAMINE (5-MeO-DMT) Formulations Pending Not granted | Beckley Psytech Limited | Pending | Not granted | ||
| Application 19/492,890 | Pharmaceutical Compositions Comprising 5-Methoxy-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) Pending Not granted | Beckley Psytech Limited | Pending | Not granted | ||
| Application 19/607,188 | 5-Methoxy-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) Powder Formulations Pending Not granted | Beckley Psytech Limited | Pending | Not granted |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Beckley Psytech Limited.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.